Search Results - "Safaian, N."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Bendamustine in patients with relapsed or refractory multiple myeloma by Michael, M, Bruns, I, Bölke, E, Zohren, F, Czibere, A, Safaian, N N, Neumann, F, Haas, R, Kobbe, G, Fenk, Roland

    Published in European journal of medical research (29-01-2010)
    “…In patients with multiple myeloma, bendamustine monotherapy is effective as 1st and 2nd line therapy. However, data for patients with advanced multiple myeloma…”
    Get full text
    Journal Article
  2. 2

    Sorafenib (Nexavar® ) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia by Safaian, N.N, Czibere, A, Bruns, I, Fenk, R, Reinecke, P, Dienst, A, Haas, R, Kobbe, G

    Published in Leukemia research (01-02-2009)
    “…Abstract The fms-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD) can be found in about one quarter of patients with acute myeloid leukemia…”
    Get full text
    Journal Article
  3. 3

    A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma by Kobbe, G., Bruns, I., Schroeder, T., Czibere, A., Warnecke, J., Hieronimus, N., Safaian, N., Kondakci, M., Saure, C., Germing, U., Haas, R., Fenk, R.

    Published in Annals of oncology (01-09-2010)
    “…We retrospectively determined whether a 3-day short course of palifermin could reduce the toxicity of high-dose therapy (HDT) and autologous blood stem-cell…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Monitoring the Agricultural Ecosystem of Paddy Fields Using Modeling Approach (A Case Study: Southern Coast of the Caspian Sea) by Safaian, N., ., C. Azadi, ., M.H. Jouri, ., R. Safaian

    “…Considering the occurrence of economic and environmental problems in the agri-ecosystems of the southern coast of the Caspian Sea, present study was conducted…”
    Get full text
    Journal Article
  6. 6

    Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD super(+) acute myeloid leukemia by Safaian, N N, Czibere, A, Bruns, I, Fenk, R, Reinecke, P, Dienst, A, Haas, R, Kobbe, G

    Published in Leukemia research (01-02-2009)
    “…The fms-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD) can be found in about one quarter of patients with acute myeloid leukemia (AML) [Small…”
    Get full text
    Journal Article